Skip to main content

Staff Blog

by Jim Shamp

Several weeks ago we at the North Carolina Biotechnology Center were asked to supply our excellent AgBiotech videos to Goodspot, a California production house that works with the Bill and Hillary Clinton Foundation to produce an annual video on world hunger.

0 comments |

Tags:
by Deborah M. Thompson, Ph.D.

We had a great turnout at the NCBiotech Job Network event on September 27,  with 42 attendees (including 6 recruiters and hiring managers).

Katie Trapp, NCBiotech’s Web Editor, gave a presentation about the value of creating a digital persona as a part of a job search strategy. She walked the attendees through various online communities (LinkedIn, Twitter, Facebook), approaches (blogging, videos) and tools (word clouds), and how to...

Read the rest of this entry →
0 comments |

Tags:
Workforce & Education, Triangle
by Robin Deacle

 

We've long touted the promise of Malcolm Thomas's company Arbovax. Still, its nice to see others recognize the promise of this growing Raleigh biotech company.

Thomas was one of twelve companies pitching a room full of potential partners and investors at Mid-Atlantic Bio.

What came through in today's pitch is both the simplicity of the approach and its broad effectiveness.

0 comments |

Tags:
by Robin Deacle

This year's pre-conference survey revealed a less-than-shocking result.

Companies are most concerned about capital.

Clovis Oncology's Patrick Mahaffy had just spoken about the "selective" IPO market and careful investors. What's an early-stage company looking for development funding to do?

At Mid-Atlantic Bio, attendees with this question crowded the room for the panel "Novel Funding Sources for Bioscience Companies." From government organizations to patient advocacy groups, the panelists had one main theme.

Get to know us.

0 comments |

Tags:
by Robin Deacle

It's hard enough to treat one virus with a pill. Chimerix is working on a therapeutic that can treat multiple viruses.

Chimerix, based in Durham, was one of two companies chosen as Showcase Companies at the Mid-Atlantic Bio conference in Bethesda today.

Tim Trost, senior vice president at Chimerix, presented clinical trial data that showed the company's treatment kept virus levels "excitingly low" in patients.

0 comments |

Tags:
by Robin Deacle

Diabetes-related treatments and a drug-discovery platform were among the dozen up-and-coming technologies presented at Mid-Atlantic Bio today.

The first session, dubbed a first look, gave companies five minutes to present what was unique about their technologies. The vision, if presented correctly, would be a bit of a tease, designed to fill the company exec's calendar with meeting requests from investors or potential partners. 

The three North Carolina pitches:

Katharos

Al Bender held up the company's product - a tube containing a matrix of material.

0 comments |

Tags:
by Jim Shamp

If you think cool medical science has to happen only where there are medical schools, you don't know how North Carolina does the life sciences these days.

Just take a gander at the beach buzz beginning in Wilmington.

Dan Baden leads a team of scientists at the University of North Carolina Wilmington’s Center for Marine Science. And believe it or not, they're moving in on starting clinical trials with a potentially game-changing cystic fibrosis therapy spun out of a nasty ocean-going algae.

0 comments |

Tags:
Research, Southeastern NC, Marine
by Jim Shamp

The day after Thanksgiving in 1960, North Carolina-born journalist Edward R. Morrow aired his last CBS TV documentary, called “Harvest of Shame.” It focused on the lousy conditions then faced by migrant farm workers.

0 comments |

Tags:
Legislation, Statewide, Agriculture

Pages